A new and alarming fungal pathogen, Candida auris (C. auris), is catalyzing a global crisis across long-term care facilities. The Centers for Disease Control and Prevention (CDC) announced C. auris to ...
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...
T2 Biosystems Inc. received a third FDA breakthrough device designation with its direct-from-blood molecular diagnostic test for Candida auris. The test joins its T2resistance panel and T2Lyme panel ...
“An inpatient has tested positive for C. auris, an emerging pathogen that is spreading in the U.S.,” a spokesperson for WVU Medicine said in a statement to local news outlets. “We are working with the ...
Add Yahoo as a preferred source to see more of our stories on Google. It was first identified in 2009 in Japan. But the Center for Disease Control and Prevention only recently deemed the fungus an ...
Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available ...
Please provide your email address to receive an email when new articles are posted on . Among 23 disinfectants tested, sporicidal disinfectants were consistently effective against C. auris. Quaternary ...
Please provide your email address to receive an email when new articles are posted on . Symptoms of Candida auris can be nonspecific, making diagnosis a challenge. It is most common in long-term ...
Candida auris, a drug-resistant fungus that spreads through healthcare facilities, is gaining ground across the United States at a pace that should concern anyone who relies on hospitals or long-term ...
Two patients previously admitted to the University of Washington Medical Center-Northwest have tested positive for Candida auris, a drug-resistant fungus that has become a growing concern in ...
Recent reports of outbreaks of the multidrug-resistant yeast Candida auris (C. auris) are worrying health officials and experts across the U.S. As of January 26, four patients in Washington with links ...